Federated Hermes’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.52K Buy
+1,261
New +$4.29K ﹤0.01% 1928
2024
Q4
Sell
-263
Closed -$380 2114
2024
Q3
$380 Buy
+263
New +$501 ﹤0.01% 2006
2020
Q4
Sell
-684
Closed -$41K 2260
2020
Q3
$41K Buy
+684
New +$34.8K ﹤0.01% 1811
2017
Q4
Sell
-122
Closed -$8K 2195
2017
Q3
$8K Hold
122
﹤0.01% 1878
2017
Q2
$9K Buy
+122
New +$7.2K ﹤0.01% 1854

Other funds holding FBIO

Federated Hermes's FBIO Position: Q1 2026 in Review

Federated Hermes opened a new position in Fortress Biotech (FBIO) in Q1 2026: 1,261 shares worth $3.52K. The stake represents ﹤0.01% of the portfolio and ranks #1928 among its holdings. This is a return to the name: Federated Hermes previously reported a position in FBIO as recently as Q3 2024.

Federated Hermes first reported a position in FBIO in Q2 2017 and has held it in 5 quarters since. The position peaked at $41K in Q3 2020. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Federated Hermes held 1,261 shares of Fortress Biotech worth $3.52K as of Q1 2026.
  • Fortress Biotech was a new Federated Hermes position in Q1 2026.
  • Fortress Biotech made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1928 holding.
  • Federated Hermes first reported a position in Fortress Biotech in Q2 2017 and has held it in 5 quarters since.
  • Federated Hermes's Fortress Biotech position peaked at $41K in Q3 2020.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.